CAS Number282526-98-1
Synonyms2-Hexadecyloxy-6-methyl-4H-3,1-benzoxazin-4-one; 2-(Hexadecycloxy)-6-methyl-4H-3,1-benzoxazin-4-one; 2-(Hexadecyloxy)-6-methyl-4H-3,1-benzoxazin-4-one; Cetilstat
Molecular FormulaC25H39O3N1
Molecular Weight401.59
Purity98.00%
Density1.0±0.1 g/cm3
Boiling Point509.7±43.0 °C at 760 mmHg
Melting Point74°C
Appearanceoff-white crystal
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 282526-98-1 |
| Catalog No. | 2A-9056286 |
| Chinese Name | 新利司他 |
| Synonyms | 2-Hexadecyloxy-6-methyl-4H-3,1-benzoxazin-4-one; 2-(Hexadecycloxy)-6-methyl-4H-3,1-benzoxazin-4-one; 2-(Hexadecyloxy)-6-methyl-4H-3,1-benzoxazin-4-one; Cetilstat |
| Molecular Formula | C25H39O3N1 |
| Molecular Weight | 401.59 |
| Purity | 98.00 |
| Density | 1.0±0.1 g/cm3 |
| Boiling Point | 509.7±43.0 °C at 760 mmHg |
| Melting Point | 74°C |
| Appearance | off-white crystal |
| Storage Condition | room temperature, dry |
| Application | Cetilistat is an inhibitor of pancreatic cancer and gastrointestinal lipase. It has a great role in the treatment of diabetic and non-diabetic obesity. |
| HTC | 2942000000 |
| MDL Number | MFCD09839697 |
| SMILES | CCCCCCCCCCCCCCCCOc1nc2ccc(C)cc2c(=O)o1 |
| InChI | InChI=1S/C25H39NO3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-19-28-25-26-23-18-17-21(2)20-22(23)24(27)29-25/h17-18,20H,3-16,19H2,1-2H3 |
| InChI Key | MVCQKIKWYUURMU-UHFFFAOYSA-N |
| MSDS | msds/56286_1_282526_98_1.pdf |
| Bioactivity | Cetilistat is an inhibitor of pancreatic and gastrointestinal lipases. It has great treatment of obesity in both diabetic and non-diabetic patients. Related Catalog Signaling Pathways >> Others >> Others Research Areas >> Metabolic Disease References [1]. Andrew Bryson, Stephan de la Motte,et al. Reduction of dietary fat absorption by the novel gastrointestinal lipase inhibitor cetilistat in healthy volunteers.Br J Clin Pharmacol. 2009 Mar; 67(3): 309-315. [2]. Melvin George, Muthukumar Rajaram,et al. New and Emerging Drug Molecules Against Obesity.J CARDIOVASC PHARMACOL THER January 2014 vol. 19 no. 1 65-76 [3]. Rebeca Carter, Angelina Mouralidarane,et al. Recent advancements in drug treatment of obesity.Clin Med October 1, 2012 vol. 12 no. 5 456-460 Chemical & Physical Properties Density 1.0±0.1 g/cm3 Boiling Point 509.7±43.0 °C at 760 mmHg Melting Point 74°C Molecular Formula C25H39NO3 Molecular Weight 401.582 Flash Point 158.9±22.6 °C Exact Mass 401.292999 PSA 52.33000 LogP 9.93 Vapour Pressure 0.0±1.3 mmHg at 25°C Index of Refraction 1.521 InChIKey MVCQKIKWYUURMU-UHFFFAOYSA-N SMILES CCCCCCCCCCCCCCCCOc1nc2ccc(C)cc2c(=O)o1 |
| Use of | Cetilistat is an inhibitor of pancreatic and gastrointestinal lipases. It has great treatment of obesity in both diabetic and non-diabetic patients. Properties Name Cetilistat Synonym More Synonyms Cetilistat Biological Activity Description Cetilistat is an inhibitor of pancreatic and gastrointestinal lipases. It has great treatment of obesity in both diabetic and non-diabetic patients. Related Catalog Signaling Pathways >> Others >> Others Research Areas >> Metabolic Disease References [1]. Andrew Bryson, Stephan de la Motte,et al. Reduction of dietary fat absorption by the novel gastrointestinal lipase inhibitor cetilistat in healthy volunteers.Br J Clin Pharmacol. 2009 Mar; 67(3): 309-315. [2]. Melvin George, Muthukumar Rajaram,et al. New and Emerging Drug Molecules Against Obesity.J CARDIOVASC PHARMACOL THER January 2014 vol. 19 no. 1 65-76 [3]. Rebeca Carter, Angelina Mouralidarane,et al. Recent advancements in drug treatment of obesity.Clin Med October 1, 2012 vol. 12 no. 5 456-460 Chemical & Physical Properties Molecular Formula C25H39NO3 Exact Mass 401.292999 PSA 52.33000 Index of Refraction 1.521 InChIKey MVCQKIKWYUURMU-UHFFFAOYSA-N |
| Transport Info | Product name: Purity: 98.0% |
| MSDS Transport Info | Module 14. Shipping information United Nations classification: inconsistent with United Nations classification standards UN number: not specified |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| Tulathromycin B | 280755-12-6 | 2A-9056278 |
| Methyl 4-(piperidin-4-yl)benzoate | 281235-04-9 | 2A-9056282 |
| 4-[trans-4-(trans-4-Methylcyclohexyl)cyclohexyl]-1-trifluoromethoxybenzene | 281680-32-8 | 2A-9056283 |
| 1,3-Bis(2,6-diisopropylphenyl)-4,5-dihydroimidazolium tetrafluoroborate | 282109-83-5 | 2A-9056284 |
| 3-Amino-3-(4-tert-butylphenyl)propanoic acid | 282524-82-7 | 2A-9056285 |
| (5R,6S)-5,6-Diphenyl-2-morpholinone | 282735-66-4 | 2A-9056288 |
| (3S)-3-(9H-Fluoren-9-ylmethoxycarbonylamino)-5-oxo-5-[tri(phenyl)methylamino]pentanoic acid | 283160-20-3 | 2A-9056290 |
| 5-Fluoro-3-hydrazonoindolin-2-one | 283584-52-1 | 2A-9056292 |
| Denibulin | 284019-34-7 | 2A-9056293 |
| 4-Amino-2,3-difluoro-5-nitrobenzoic acid | 284030-57-5 | 2A-9056294 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS